← back to ranking

NBIX · Neurocrine Biosciences, Inc.

Biotechnology · mkt cap $15.6B · calls: Q1 FY2026 vs Q4 FY2025
3.0 conviction · conf-adj 3

conf –

triage_only:3.0

Enthusiasm latest / prev ()

No AI/ML discussion; focus is drug sales and clinical pipeline.